Watson, H (2012). «Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.». British Journal of Haematology159 (5): 528-40. PMID23043677. S2CID5104368. doi:10.1111/bjh.12059.
Kelton JG, Warkentin TE (Octubre de 2008). «Heparin-induced thrombocytopenia: a historical perspective». Blood112 (7): 2607-16. PMID18809774. doi:10.1182/blood-2008-02-078014.
Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI (Junio de 2008). «Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)». Chest133 (6 Suppl): 141S-159S. PMID18574264. doi:10.1378/chest.08-0689.
Dooley C, Kaur R, Sobieraj DM (2014). «Comparison of the efficacy and safety of low molecular weight heparins for venous thromboembolism prophylaxis in medically ill patients.». Curr Med Res Opin30 (3): 367-80. PMID23971722. S2CID206967565. doi:10.1185/03007995.2013.837818.
Hirsh J, Heddle N, Kelton J (2004). «Treatment of heparin-induced thrombocytopenia: a critical review». Arch Intern Med164 (4): 361-9. PMID14980986. doi:10.1001/archinte.164.4.361.
Lindhoff-Last E, Eichler P, Stein M, Plagemann J, Gerdsen F, Wagner R, Ehrly AM, Bauersachs R (Marzo de 2000). «A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery». Thromb. Res.97 (6): 387-93. PMID10704647. doi:10.1016/s0049-3848(99)00198-x.
Weismann RE, Tobin RW (Febrero de 1958). «Arterial embolism occurring during systemic heparin therapy». AMA Arch Surg76 (2): 219-25; discusiones 225-7. PMID13497418. doi:10.1001/archsurg.1958.01280200041005.
Watson, H (2012). «Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.». British Journal of Haematology159 (5): 528-40. PMID23043677. S2CID5104368. doi:10.1111/bjh.12059.
Kelton JG, Warkentin TE (Octubre de 2008). «Heparin-induced thrombocytopenia: a historical perspective». Blood112 (7): 2607-16. PMID18809774. doi:10.1182/blood-2008-02-078014.
Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI (Junio de 2008). «Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)». Chest133 (6 Suppl): 141S-159S. PMID18574264. doi:10.1378/chest.08-0689.
Dooley C, Kaur R, Sobieraj DM (2014). «Comparison of the efficacy and safety of low molecular weight heparins for venous thromboembolism prophylaxis in medically ill patients.». Curr Med Res Opin30 (3): 367-80. PMID23971722. S2CID206967565. doi:10.1185/03007995.2013.837818.
Hirsh J, Heddle N, Kelton J (2004). «Treatment of heparin-induced thrombocytopenia: a critical review». Arch Intern Med164 (4): 361-9. PMID14980986. doi:10.1001/archinte.164.4.361.
Lindhoff-Last E, Eichler P, Stein M, Plagemann J, Gerdsen F, Wagner R, Ehrly AM, Bauersachs R (Marzo de 2000). «A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery». Thromb. Res.97 (6): 387-93. PMID10704647. doi:10.1016/s0049-3848(99)00198-x.
Weismann RE, Tobin RW (Febrero de 1958). «Arterial embolism occurring during systemic heparin therapy». AMA Arch Surg76 (2): 219-25; discusiones 225-7. PMID13497418. doi:10.1001/archsurg.1958.01280200041005.
Rhodes GR, Dixon RH, Silver D (Marzo de 1973). «Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations». Surg Gynecol Obstet136 (3): 409-16. PMID4688805.
semanticscholar.org
api.semanticscholar.org
Watson, H (2012). «Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.». British Journal of Haematology159 (5): 528-40. PMID23043677. S2CID5104368. doi:10.1111/bjh.12059.
Dooley C, Kaur R, Sobieraj DM (2014). «Comparison of the efficacy and safety of low molecular weight heparins for venous thromboembolism prophylaxis in medically ill patients.». Curr Med Res Opin30 (3): 367-80. PMID23971722. S2CID206967565. doi:10.1185/03007995.2013.837818.